We now have the strongest evidence to date that radio waves from mobile phones are not a hazard to human health.
Academic rigour, journalistic flair
Articles on Brain cancer
Displaying 1 - 20 of 21 articles
Cancer vaccines have gained much interest among scientists but face a number of hurdles. A new mRNA vaccine for glioma offers a step forward in training the immune system to fight cancer.
Over 20% of people diagnosed with brain cancer survive longer than five years. But the NDIS may not recognise their need for support to live, work, learn and play.
Glioblastoma is the most aggressive type of brain cancer, causing significant decline in cognitive function. New research suggests a common anti-seizure drug could help control tumor growth.
Public-health messaging and strained health-care resources during COVID-19 have meant fewer in-person exams. For some children with brain cancer, this can have devastating consequences.
Developing drugs is typically the domain of large pharmaceutical companies. But here is an example of drug development for a rare pediatric brain cancer that was done in a university setting.
When it comes to treating cancer, focus for decades has been on killing the fastest growing cells. New research finds that this approach may be too simple.
A cancer is in remission when it can no longer be detected. But we only say it’s cured when it hasn’t come back for a certain time – and that differs for different cancers.
Why hasn’t there been an improvement in survival in the last 30 years for patients with brain cancers?
Leukaemia used to be a death sentence. Now, the survival rate for the most common form in children is 85%. We can apply similar strategies to how we approach childhood brain cancer.
A diagnosis of glioblastoma did not keep John McCain from the Capitol to cast a crucial vote that could end Obamacare. His actions are a reminder that stats are one thing but human beings, another.
If you’re an Australian teenager or young adult diagnosed with cancer, there’s good news: overall survival rates are good and getting better. But what can you expect from life after cancer treatment?
The well-used drug clomipramine could target tumour cells and leave normal cells healthy – if scientists could get enough evidence for it.
The evidence appears contradictory – but there may be a good reason for this.
Childhood deaths from cancer have decreased by nearly 40% in the past 15 years in Australia. But some types of childhood cancer have shown little improvement.
A new research paper has found some cancers aren’t picked up by GPs in the first or second appointments, but it’s because cancer is usually an unlikely explanation for a patient’s symptoms.
Early intervention in neurocognition and communication can address communication and cognition difficulties in survivors of childhood brain cancer and increase their quality of life.
By tampering with the machinery which allows aggressive cancer cells to adapt, we can disrupt their ecosystem.
Studies have found that doctors often overestimate survival in terminally ill patients, not the other way round.
While I can’t fault Carrie Bickmore for trying to get attention for the disease that prematurely killed her husband, her move does raise questions about how research should be funded.
Top contributors
-
Associate Professor (conjoint), Children's Cancer Institute
-
Senior Lecturer in Ethics and Professionalism, University of Adelaide
-
Research Fellow, European Cancer Stem Cell Research Institute, Cardiff University
-
Consultant Neonatologist and Professor of Ethics, University of Oxford
-
Lecturer & Research Fellow in Speech Pathology, University of Sydney
-
Adjunct Professor of Biochemistry, University of Helsinki
-
Professor of Cellular and Molecular Neuro-Oncology, University of Portsmouth
-
Senior Research Fellow, St George's, University of London
-
Adjunct Professsor, School of Psychology, Faculty of Health and Medical Sciences, University of Adelaide
-
University of Florida
-
Lecturer in Neuroscience, University of Central Lancashire
-
NHMRC Senior Research Fellow, Centre for Cancer Biology, University of South Australia
-
Adjunct Associate Professor, Cancer Nursing Research Unit, University of Sydney
-
Research Associate, Centre for Cancer Biology, University of South Australia
-
Professor of Primary Care Cancer Research, The University of Melbourne
